Can the name of a drug affect consumer perception? FDA wants to know!
“The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on a proposed study entitled “Empirical Study of Promotional Implications of Proprietary Prescription Drug Names.””
“The proposed study is designed to provide systematic, empirical evidence to answer two research questions:
- Primary research question: How, if at all, do names that suggest the drug’s indication affect consumers’ and/or healthcare providers’ perceptions of the prescription drug?
- Secondary research question: How, if at all, do names that suggest an overstatement of the efficacy of the drug affect consumers’ and/or healthcare providers’ perceptions of prescription drugs?”
Recent Posts
